Stock Research: Quidel

Peer-based, data-driven stock research by Obermatt enables quick and easy due diligence for your stock investing.

What's New

Recent improvements to enhance your investment research experience

360° View free for everyone

Our most comprehensive analysis—the 360° View—is now free for everyone. To maintain our research quality, other ranks are now part of our new subscription plans.

3 new subscription models

Plans for every investor - from stock ideas to in-depth analysis.

Similar Stocks

Four stock alternatives to the stock you're searching.

Quidel

NasdaqGS:QDEL US2197981051
12
  • Value
    17
  • Growth
    21
  • Safety
    Safety
    88
  • Combined
    25
  • Sentiment
    12
  • 360° View
    360° View
    12
Unlock
Which ranks are driving this 360° View?
Subscribe to View
Company Description

QuidelOrtho Corporation develops and manufactures in vitro diagnostics. It operates in immunoassay and molecular testing, clinical chemistry, and transfusion medicine. Key brands include AdenoPlus, BIOVUE, and Lyra. In the last fiscal year, the company had $1896 million market cap, $1287 million profits, $2783 million revenue, and 6600 employees.

more
Analysis

ANALYSIS: With an Obermatt 360° View of 12 (better than 12% compared with alternatives), overall professional sentiment and financial characteristics for the stock Quidel are critical, mostly below average. The 360° View is based on consolidating four consolidated indicators, with three out of four indicators below average for Quidel. Only the consolidated Value Rank has an attractive rank of 88, which means that the share price of Quidel is on the lower side compared with the typical size in indicators such as revenues, profits, and invested capital. This means that the stock price is lower than for 88% of alternative stocks in the same industry. All other consolidated ranks are below average. The consolidated Growth Rank has a low rank of 21, which means that the company exhibits below-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth as well as stock returns. The consolidated Safety Rank has a riskier rank of 17, meaning the company has a riskier financing structure than 83% comparable companies when looking at the amount of its debt, its refinancing requirements, and its ability to service debt. Finally, professionals are more pessimistic about the stock than for 88% of alternative investment opportunities, reflected in the consolidated Sentiment Rank of 12. ...read more

more
Index
NASDAQ
S&P MIDCAP
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 10-Sep-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
88 87 90 97
Growth
21 43 5 1
Safety
Safety
17 4 45 100
Sentiment
12 14 8 99
360° View
360° View
12 7 7 98
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
39 31 42 56
Opinions Change
65 31 17 98
Pro Holdings
n/a 53 8 81
Market Pulse
3 7 24 58
Sentiment
12 14 8 99
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
88 87 90 97
Growth
21 43 5 1
Safety Safety
17 4 45 100
Combined
25 33 39 77
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
82 71 86 100
Price vs. Earnings (P/E)
88 83 74 66
Price vs. Book (P/B)
91 83 86 91
Dividend Yield
1 1 1 1
Value
88 87 90 97
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
6 19 8 1
Profit Growth
75 85 12 38
Capital Growth
25 55 12 1
Stock Returns
27 35 45 25
Growth
21 43 5 1
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
28 24 28 82
Refinancing
22 26 27 57
Liquidity
48 18 86 98
Safety Safety
17 4 45 100

Similar Stocks

Discover high‑ranked alternatives to Quidel and broaden your portfolio horizons.

Meta

NasdaqGS:FB
Country: USA
Industry: Interactive Media & Services
Size: XX-Large
Full Stock Analysis

Lithia Motors

NYSE:LAD
Country: USA
Industry: Automotive Retail
Size: X-Large
Full Stock Analysis

Micron

NasdaqGS:MU
Country: USA
Industry: Semiconductors
Size: X-Large
Full Stock Analysis

Alphabet

NasdaqGS:GOOG.L
Country: USA
Industry: Interactive Media & Services
Size: XX-Large
Full Stock Analysis

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.